BiVictriX Therapeutics (BVX)

Sector:

Pharma and Biotech

 18.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 25.50
  • 52 Week Low: 18.00
  • Currency: UK Pounds
  • Shares Issued: 66.12m
  • Volume: 0
  • Market Cap: £12.23m

BVX Overview

BVX has identified a unique, cancer-restricted antigen fingerprint, absent from healthy cells, which can be exploited to produce cancer selective therapeutics. The Bi-Cygni® technology has been developed to exploit this concept and expedite the development of bispecific therapeutics with an improved therapeutic index. Based on BVX's work to date, these ADCs demonstrate superior potency and tumour selectivity compared to conventional ADCs. The main country of operation is in the UK.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

BVX Fundamentals

Fundamentals data is not available for this company.

BVX Company Announcements

Director Dealing 23-Sep-2021 12:50 RNS
BiVictriX and IONTAS complete two campaigns 22-Sep-2021 07:01 RNS
Interim Results 22-Sep-2021 07:00 RNS

BVX ShareCast News

No recent information was found.

Latest BVX Director Deals

Traded Action Notifier PriceAmountValue
22-Sep-21 Buy Iain Gladstone Ross 19.45p 25,645 £4,987.95
22-Sep-21 Buy Iain Gladstone Ross 19.45p 30,848 £5,999.94
22-Sep-21 Buy Iain Gladstone Ross 19.38p 43,507 £8,429.48

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

BVX Market Data

Currency UK Pounds
Share Price 18.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 25.50
52 Week Low 18.00
Volume 0
Shares Issued 66.12m
Market Cap £12.23m

BVX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
18.42% below the market average18.42% below the market average18.42% below the market average18.42% below the market average18.42% below the market average
4.76% above the sector average4.76% above the sector average4.76% above the sector average4.76% above the sector average4.76% above the sector average
Income Not Available
Growth Not Available

BVX Dividends

No dividends found

Trades for --2021

Time Volume / Share Price
0 @ 0.000p

BVX Key Personnel

CEO Tiffany Jane Thorn

Top of Page